Skip to Content

Sponsored

Artificial intelligence

Smaller, smarter, healthier

New medical technologies are making chronic-care management more consistent and effective—reducing health-care costs and transforming lives.

Produced in association withMedtronic

Joe just had a pacemaker implanted to deliver electrical pulses to the right ventricle of his heart, to prevent his heartbeat from stopping and keep him from losing consciousness. His entire pacemaker, about the size of a large vitamin capsule, is slipped directly into place in the heart through a vein. Unlike a traditional pacemaker, there’s no box under the skin and no wires. He goes home a few hours later. Instead of delivering pulses at a preset level every few minutes as the first implanted pacemakers did, Joe’s pacemaker monitors the electrical activity in his heart by the microsecond and delivers pulses only as needed.

Smaller, smarter, healthier

“This is a closed-loop system,” says Alan Cheng, vice president for clinical research and therapy development, cardiac rhythm management, at Medtronic, a global medical technology company. Cheng is a clinical electrophysiologist and also serves as an associate professor at The Johns Hopkins University School of Medicine. “The pacemaker has two main jobs: to sense what’s going on in the heart, and to pace the heart if it doesn’t see enough electrical activity. It’s taking inputs on what the intrinsic rhythm is, and if it falls below, the device will start pacing and keep it up until the heart regains its rhythm.”

Joe will still have a follow-up appointment, but his doctor today will have weeks’ worth of data to help answer the critical question, “So, how’s the new pacemaker?” The data collected, from Joe’s pacemaker and thousands of other patients, will help refine the algorithms that monitor the heart and control the pulses.

Such advances in miniaturization and artificial intelligence are enabling the development of ingenious devices to help monitor and treat numerous chronic conditions—not only heart disease, but also diabetes Parkinson’s disease, cancer, epilepsy, obesity, chronic pain, and many others.

Deep Dive

Artificial intelligence

What does GPT-3 “know” about me? 

Large language models are trained on troves of personal data hoovered from the internet. So I wanted to know: What does it have on me?

An AI that can design new proteins could help unlock new cures and materials 

The machine-learning tool could help researchers discover entirely new proteins not yet known to science.

DeepMind’s new chatbot uses Google searches plus humans to give better answers

The lab trained a chatbot to learn from human feedback and search the internet for information to support its claims.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.